Crossref
Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer
Neoplasma · 2009
DOI: 10.4149/neo_2009_01_68 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neoplasma, 2009. Verfasst von S K Batabyal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Biochemistry Department, Nightingale Hospital, Kolkata, India. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AgedBiomarkers, TumorChromatography, High Pressure LiquidElectrophoresis, Polyacrylamide GelGlycosylationHumansLectinsMaleMiddle AgedPhytohemagglutininsProstate-Specific AntigenProstatic HyperplasiaProstatic Neoplasms
Substanzen
Biomarkers, TumorLectinsPhytohemagglutininsphytohemagglutinin L protein, Phaseolus vulgarisProstate-Specific Antigen
Autor:innen und Institutionen
- Advanced Biochemistry Department, Nightingale Hospital, Kolkata, India.
Zitieren
APA
Batabyal, S. K., Majhi, R., & Basu, P. S. (2009). Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer. Neoplasma. https://doi.org/10.4149/neo_2009_01_68
Vancouver
Batabyal SK, Majhi R, Basu PS. Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer. Neoplasma. 2009. doi:10.4149/neo_2009_01_68
BibTeX
@article{Batabyal2009,
author = {Batabyal, S K and Majhi, R and Basu, P S},
title = {Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer},
journal = {Neoplasma},
year = {2009},
doi = {10.4149/neo_2009_01_68}
}
EUVIMED